Showing results (1-10 of 123) with videos related to
Sort By:
Pageof 13
Hematology/Oncology Clinics of North America|October 14, 2015
The Role of Hematopoietic Stem Cell Transplantation in Treatment of Hemophagocytic LymphohistiocytosisSarah NikiforowHematology. American Society of Hematology. Education Program|December 6, 2015
The unique aspects of presentation and diagnosis of hemophagocytic lymphohistiocytosis in adultsSarah Nikiforow, Nancy BerlinerCell Stem Cell|January 11, 2016
Dramatic Expansion of HSCs: New Possibilities for HSC Transplants?Sarah Nikiforow, Jerome RitzJournal for Immunotherapy of Cancer|April 22, 2017
The Why, what, and How of the New FACT standards for immune effector cellsMarcela V Maus, Sarah NikiforowHematology. American Society of Hematology. Education Program|February 20, 2015
Maximizing GVL in allogeneic transplantation: role of donor lymphocyte infusionsSarah Nikiforow, Edwin P AlyeaHematology/Oncology Clinics of North America|April 16, 2025
Role of Hematopoietic Cell Transplantation in Pediatric and Adult Hemophagocytic Lymphohistiocytosis-Remaining Unknowns and ChallengesSarah Nikiforow, Christine N DuncanBlood|November 25, 2025
Hemophagocytic Lymphohistiocytosis in AdultsJoanne Ino Hsu, Sarah Nikiforow, Nancy BerlinerJournal of Virology|October 29, 2003
Cytolytic CD4(+)-T-cell clones reactive to EBNA1 inhibit Epstein-Barr virus-induced B-cell proliferationSarah Nikiforow, Kim Bottomly, George Miller, et al.Seminars in Nephrology|March 30, 2024
Adoptive Immune Effector Cell Therapies in Cancer and Solid Organ Transplantation: A ReviewBrittany Schreiber, Sudipta Tripathi, Sarah Nikiforow, et al.Frontiers in Immunology|March 4, 2021
Global Perspective on the Development of Genetically Modified Immune Cells for Cancer TherapyLaetitia Pinte, Amy Cunningham, Helene Trébéden-Negre, et al.Pageof 13